Jonathan Wong
The Latest
-
PepsiCo Trims Revenue Outlook Amidst Declining Snack and Beverage Sales
PepsiCo, the world's leading snack and beverage company, has revised its revenue outlook for the year downward, citing weakened demand in its core North American market and the impact of product recalls. The company's latest financial results reveal challenges across several key segments, as consumers react to persistent price increases and competition in the food and beverage industry intensifies. 
PepsiCo, the world's leading snack and beverage company, has revised its revenue outlook for the year downward, citing weakened demand in its core North American market and the impact of product recalls. The company's latest financial results reveal challenges across several key segments, as consumers react to persistent price increases and competition in the food and beverage industry intensifies. -
Spirit Airlines Under Fire for Removing Passengers Wearing Crop Tops
Spirit Airlines is facing criticism after two Southern California women were removed from a flight due to their attire. The women, Tara Kehidi and Teresa Araujo, claim they were asked to leave the plane because they were wearing crop tops, sparking debates about Spirit's dress code policies and how they are enforced. 
Spirit Airlines is facing criticism after two Southern California women were removed from a flight due to their attire. The women, Tara Kehidi and Teresa Araujo, claim they were asked to leave the plane because they were wearing crop tops, sparking debates about Spirit's dress code policies and how they are enforced. -
Apple Downgraded Amid Concerns Over iPhone Demand and AI Prospects
Apple Inc. (NASDAQ: AAPL) is facing headwinds as Jefferies downgraded the tech giant's stock rating from "Buy" to "Hold," citing concerns over inflated market expectations for its upcoming iPhone models and the slow pace of its artificial intelligence (AI) advancements. The decision to downgrade comes at a critical time for Apple as it strives to maintain its dominant position in the highly competitive smartphone market while navigating new challenges in AI technology. 
Apple Inc. (NASDAQ: AAPL) is facing headwinds as Jefferies downgraded the tech giant's stock rating from "Buy" to "Hold," citing concerns over inflated market expectations for its upcoming iPhone models and the slow pace of its artificial intelligence (AI) advancements. The decision to downgrade comes at a critical time for Apple as it strives to maintain its dominant position in the highly competitive smartphone market while navigating new challenges in AI technology. -
Thyssenkrupp Reconsiders Green Steel Plans Amid Soaring Costs
Thyssenkrupp AG, the German industrial conglomerate, is facing a critical juncture in its push to produce "green steel," with the company now reexamining its ambitious plans to transition its steel production to hydrogen-based processes. The review comes in response to escalating costs and internal challenges, putting the future of the project in question and raising concerns about the feasibility of its decarbonization strategy. 
Thyssenkrupp AG, the German industrial conglomerate, is facing a critical juncture in its push to produce "green steel," with the company now reexamining its ambitious plans to transition its steel production to hydrogen-based processes. The review comes in response to escalating costs and internal challenges, putting the future of the project in question and raising concerns about the feasibility of its decarbonization strategy. -
Starboard Value Targets Pfizer for Turnaround with $1 Billion Stake
Activist investor Starboard Value has acquired a significant stake in Pfizer, valued at around $1 billion, as it aims to drive a strategic overhaul at the struggling pharmaceutical giant. The move comes as Pfizer faces mounting challenges, including dwindling revenue from its COVID-19 products and concerns over its recent acquisition strategy. The activist firm's push for change could signal a new chapter in the company's efforts to recapture its former financial strength. 
Activist investor Starboard Value has acquired a significant stake in Pfizer, valued at around $1 billion, as it aims to drive a strategic overhaul at the struggling pharmaceutical giant. The move comes as Pfizer faces mounting challenges, including dwindling revenue from its COVID-19 products and concerns over its recent acquisition strategy. The activist firm's push for change could signal a new chapter in the company's efforts to recapture its former financial strength. -
Rivian Slashes Production Forecast Due to Parts Shortage, Shares Drop as EV Demand Slows
Rivian Automotive, the electric vehicle (EV) startup backed by Amazon, has reduced its full-year production forecast, citing supply chain disruptions and a shortage of key components. The company also missed third-quarter delivery expectations, causing its stock to drop by about 4% in early trading on Friday. Rivian now expects to produce between 47,000 and 49,000 vehicles in 2024, a sharp decrease from its earlier target of 57,000 units. 
Rivian Automotive, the electric vehicle (EV) startup backed by Amazon, has reduced its full-year production forecast, citing supply chain disruptions and a shortage of key components. The company also missed third-quarter delivery expectations, causing its stock to drop by about 4% in early trading on Friday. Rivian now expects to produce between 47,000 and 49,000 vehicles in 2024, a sharp decrease from its earlier target of 57,000 units. -
Eli Lilly Unveils $4.5 Billion Plan for Cutting-Edge Research and Manufacturing Center
Eli Lilly, the pharmaceutical giant behind some of the most successful drugs in recent years, has announced plans to invest $4.5 billion in a new research and manufacturing center in Indiana. 
Eli Lilly, the pharmaceutical giant behind some of the most successful drugs in recent years, has announced plans to invest $4.5 billion in a new research and manufacturing center in Indiana. -
Tesla's Third-Quarter Delivery Miss Sends Stock Down, Struggles with Rivals in China and Europe
Tesla, the world's leading electric vehicle (EV) manufacturer, reported its third-quarter delivery numbers on Wednesday, falling short of Wall Street's expectations and causing its shares to dip by 3.5% in premarket trading. The EV maker delivered 462,890 vehicles between July and September, marking a 6.4% increase from the previous quarter. However, this fell below analysts' average forecast of 469,828 deliveries, a key indicator closely monitored by investors. 
Tesla, the world's leading electric vehicle (EV) manufacturer, reported its third-quarter delivery numbers on Wednesday, falling short of Wall Street's expectations and causing its shares to dip by 3.5% in premarket trading. The EV maker delivered 462,890 vehicles between July and September, marking a 6.4% increase from the previous quarter. However, this fell below analysts' average forecast of 469,828 deliveries, a key indicator closely monitored by investors. -
Union Calls on Boeing CEO to Step In as Healthcare Benefits for Striking Workers Are Cut
Boeing's labor dispute intensified this week after the company cut off healthcare benefits for around 33,000 striking workers, sparking renewed calls from the union for CEO Kelly Ortberg to intervene personally. The International Association of Machinists (IAM) and Aerospace Workers, representing the employees, urged the newly appointed CEO to step in and engage directly in negotiations. The strike, which began on September 13, has disrupted production of Boeing's top-selling 737 MAX jets and appears far from resolution. 
Boeing's labor dispute intensified this week after the company cut off healthcare benefits for around 33,000 striking workers, sparking renewed calls from the union for CEO Kelly Ortberg to intervene personally. The International Association of Machinists (IAM) and Aerospace Workers, representing the employees, urged the newly appointed CEO to step in and engage directly in negotiations. The strike, which began on September 13, has disrupted production of Boeing's top-selling 737 MAX jets and appears far from resolution. -
CVS Explores Radical Break-Up Amid $1 Billion Cost-Cutting Crisis: Report
CVS Health Corp. is reportedly exploring a potential break-up of its retail and insurance units as the company grapples with increasing investor pressure and a depressed stock price. According to sources familiar with the matter, CVS has engaged financial advisors to assess various options, including separating its pharmacy operations from its insurance business, in a bid to rejuvenate its struggling operations. 
CVS Health Corp. is reportedly exploring a potential break-up of its retail and insurance units as the company grapples with increasing investor pressure and a depressed stock price. According to sources familiar with the matter, CVS has engaged financial advisors to assess various options, including separating its pharmacy operations from its insurance business, in a bid to rejuvenate its struggling operations.
